SCHEMBL4710075

SCHEMBL4710075

OCc1cccc(C=Cc2ccccc2)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 5/20 0.56
ALDH1A1 P00352 4/20 0.56
KDM4E B2RXH2 4/20 0.56
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
HPGD P15428 3/20 0.56
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
PKM P14618 2/20 0.56
HDAC6 Q9UBN7 2/20 0.56
GRM5 P41594 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
TSHR P16473 1/20 0.56
NFKB1 P19838 1/20 0.56
CYP2C19 P33261 1/20 0.56
THPO P40225 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4710071 1.00 GRM4 (0.56) GRM4ALDH1A1KDM4EMEN1KMT2A
SCHEMBL4712680 1.00 GRM4 (0.56) GRM4ALDH1A1KDM4EMEN1KMT2A
SCHEMBL5865203 0.82 GRM4 (0.61) GRM4ALDH1A1KDM4EMEN1KMT2A
SCHEMBL5865200 0.82 GRM4 (0.61) GRM4ALDH1A1KDM4EMEN1KMT2A
SCHEMBL20314432 0.82 GRM4 (0.61) GRM4ALDH1A1KDM4EMEN1KMT2A
Hydrochloric Acid SCHEMBL5865201 0.81 GRM4 (0.59) GRM4ALDH1A1KDM4EMEN1KMT2A
Hydrochloric Acid SCHEMBL5865204 0.81 GRM4 (0.59) GRM4ALDH1A1KDM4EMEN1KMT2A
SCHEMBL10665839 0.80 GRM4 (0.73) GRM4ALDH1A1KDM4EMEN1KMT2A
SCHEMBL10665836 0.80 GRM4 (0.73) GRM4ALDH1A1KDM4EMEN1KMT2A
SCHEMBL3615048 0.77 KDM4E (0.50) ALDH1A1KDM4EMEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP claimed
CN-1262676-A Pyridine derivatives NOVARTIS AG (CH) 2000-08-09 CN claimed
EP-0998459-A2 PYRIDINE DERIVATIVES Novartis AG (CH) 2000-05-10 EP claimed
WO-1999002497-A2 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 1999-01-21 WO claimed
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP disclosed
CN-1203060-C Pyridine derivatives, compositions and uses thereof NOVARTIS AG (CH) 2005-05-25 CN disclosed
US-6656957-B1 Marked and selective modulating, especially antagonistic, action at human metabotropic glutamate receptors (mGluRs); treatment of disorders such as epilepsy, cerebral ischemias, especially acute ischemias, spasticity etc. NOVARTIS AG (CH) 2003-12-02 US disclosed
CN-1262676-A Pyridine derivatives NOVARTIS AG (CH) 2000-08-09 CN disclosed